# Simultaneously Integrated Dose Escalation for Locally Advanced Cervical Cancer

> **NCT02879214** · PHASE2 · UNKNOWN · sponsor: **Sichuan Provincial People's Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of Cervix

## Interventions

- **RADIATION:** Simultaneous boost along with chemo

## Key facts

- **NCT ID:** NCT02879214
- **Lead sponsor:** Sichuan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2019-12
- **Final completion:** 2020-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02879214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02879214, "Simultaneously Integrated Dose Escalation for Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02879214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*